Federal High Court, Abuja
The Federal High Court sitting in Abuja on Monday ordered the Federal Government to pay $951m to the Bayelsa State Government as the 13 per cent derivative sum due as arrears of revenue payable to the state government.
While delivering the judgment, Justice Inyang Ekwo held that the Attorney General of the Federation failed to enter his defence in the case, prompting the court to declare the plaintiff’s claim as unchallenged.
He said, “Where the person to whom such a demand notice is issued takes no steps, he is deemed to have admitted the claims, thereby giving the other person the option of enforcing the claims by the available procedures for enforcement of undisputed claims. That is what has happened in this case.
“I find no material upon which I can grant leave of this court for the defendant to enter a defence or transfer this matter to the general cause list.
“In that case, I also find that the case of the plaintiff remains not only unchallenged, but admitted and therefore must succeed on the merit.
“Judgment is hereby entered on the claims of the plaintiff in this case. This is the order of this court.”
In suit No FHC/ABJ/CS/175/2021 filed on February 12, 2021, a Senior Advocate of Nigeria, Ken Njemanze, had filed the suit on behalf of the Bayelsa State Government, asking the court for “an order directing the defendant (AGF) to pay the sum of $951,190,840, being the 13% derivative sum due as arrears of revenue and payable to the Bayelsa State as assessed, completed, and calculated by the body set up by the Honourable Attorney General of the Federation, pursuant to paragraph B (iii) (b) of the terms of settlement made by the (consent) judgment of the court by the Supreme Court in suit No: SC 964/2016 Attorney General of Rivers State and Others Vs Attorney General of the Federation, on the 17th day of October 2018; 10% post-judgment interest at the court rate on the said sum of $951,190,840 until final liquidation thereof.”
Copyright Bioreports News.
All rights reserved. This material, and other digital content on this website, may not be reproduced, published, broadcast, rewritten or redistributed in whole or in part without prior express written permission from Bioreports News.
Contact: [email protected]